Topic - Immunomedics

Immunomedics is a pharmaceutical company focusing on the development of antibody-drug conjugates for the treatment of cancer. - Source: Wikipedia

Related Stories

A woman walks past a bank's electronic board showing the Hong Kong share index at Hong Kong Stock Exchange Monday, Sept. 14, 2020. Asian shares are rising, despite the rollercoast ride that closed Wall Street last week, as traders awaited cues from the U.S. central bank expected later in the week. (AP Photo/Vincent Yu)

Asian markets mixed after Wall Street rises on dealmaking

By JOE McDONALD - Associated Press

FILE - This April 30, 2020, file photo shows Gilead Sciences headquarters in Foster City, Calif. Shares of Immunomedics more than doubled before the market open on Monday, Sept. 14 after Gilead Sciences said it'll buy the biotechnology company for $21 billion. (AP Photo/Ben Margot, File)

Gilead Sciences buying Immunomedics in $21 billion deal

Associated Press